REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmeca A.S. (Czech Republic)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Pharmeca A.S. Profile Updated: October 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharmeca A.S. is based in Czech Republic. The head office is in Prague. The enterprise operates in the Administrative Management and General Management Consulting Services industry. It was first established on May 25, 2012. It currently has a total number of 10 - 19 (2023) employees. In 2022, the company reported a net sales revenue drop of 14.46%. Its’ total assets recorded a growth of 24.02%. The net profit margin of Pharmeca A.S. decreased by 11.78% in 2022.

Headquarters
Hradesinska 2144/47
Prague; The City of Prague; Postal Code: 10100

Contact Details: Purchase the Pharmeca A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmeca A.S. report to view the information.
Outstanding Shares:
Purchase the Pharmeca A.S. report to view the information.
Registered Capital:
Purchase the Pharmeca A.S. report to view the information.
Incorporation Date:
May 25, 2012
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Centrum Zdravi Milovice S.R.O.
5%
Company Performance
Financial values in the chart are available after Pharmeca A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-14.46%
Total operating revenue
-16.05%
Operating profit (EBIT)
-59.3%
EBITDA
-53.67%
Net Profit (Loss) for the Period
-60.08%
Total assets
24.02%
Total equity
5.88%
Operating Profit Margin (ROS)
-14.49%
Net Profit Margin
-11.78%
Return on Equity (ROE)
-10.43%
Quick Ratio
-4.38%
Cash Ratio
-2.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?